Oncotype DX for Comprehensive Treatment in Male Breast Cancer: A Case Report and Literature Review:
作者： Ang Zheng , Lin Zhang , Ziyao Ji , Lijuan Fan , Feng Jin
关键词: Clinical Practice 、 Oncotype DX 、 Medicine 、 Male breast cancer 、 Internal medicine 、 Oncology 、 Endocrine therapy
摘要: Male breast cancer (MBC) is uncommon in clinical practice. Using the 21-gene assay to facilitate decision-making on comprehensive treatment of MBC rarely reported. This study reports case of...
sagepub.com
doaj.org参考文章(35)
Maureen Cronin, Mylan Pho, Debjani Dutta, James C. Stephans, Steven Shak, Michael C. Kiefer, Jose M. Esteban, Joffre B. Baker, Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. American Journal of Pathology. ,vol. 164, pp. 35- 42 ,(2004) , 10.1016/S0002-9440(10)63093-3
S. Shak, G. Palmer, F. L. Baehner, C. Millward, D. Watson, G. W. Sledge, Molecular characterization of male breast cancer by standardized quantitative RT-PCR analysis: First large genomic study of 347 male breast cancers compared to 82,434 female breast cancers Journal of Clinical Oncology. ,vol. 27, pp. 549- 549 ,(2009) , 10.1200/JCO.2009.27.15_SUPPL.549
Muhammad Habibullah Khan, Rozenn Allerton, Laura Pettit, None, Hormone Therapy for Breast Cancer in Men Clinical Breast Cancer. ,vol. 15, pp. 245- 250 ,(2015) , 10.1016/J.CLBC.2015.01.007
Tal Grenader, Rinat Yerushalmi, Margarita Tokar, Georgeta Fried, Bella Kaufman, Tamar Peretz, David B. Geffen, The 21-Gene Recurrence Score Assay (Oncotype DX) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort Oncology. ,vol. 87, pp. 1- 6 ,(2014) , 10.1159/000360793
Bernard Fisher, Joseph Costantino, Carol Redmond, Roger Poisson, David Bowman, Jean Couture, Nikolay V Dimitrov, Norman Wolmark, D Lawrence Wickerham, Edwin R Fisher, Richard Margolese, Andre Robidoux, Henry Shibata, Jose Terz, AHG Paterson, Merrill I Feldman, William Farrar, James Evans, H Lavina Lickley, Mary Ketner, *, None, A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors New England Journal of Medicine. ,vol. 320, pp. 479- 484 ,(1989) , 10.1056/NEJM198902233200802
Scott V. Bratman, Daniel S. Kapp, Kathleen C. Horst, Evolving trends in the initial locoregional management of male breast cancer. The Breast. ,vol. 21, pp. 296- 302 ,(2012) , 10.1016/J.BREAST.2012.01.008
I. Craig Henderson, Anthony J. Patek, The relationship between prognostic and predictive factors in the management of breast cancer Breast Cancer Research and Treatment. ,vol. 52, pp. 261- 288 ,(1998) , 10.1023/A:1006141703224
Elisa Rush Port, Jane V. Fey, Hiram S. Cody, Patrick I. Borgen, Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer. ,vol. 91, pp. 319- 323 ,(2001) , 10.1002/1097-0142(20010115)91:2<319::AID-CNCR1004>3.0.CO;2-D
Laura Ottini, Male breast cancer: a rare disease that might uncover underlying pathways of breast cancer Nature Reviews Cancer. ,vol. 14, pp. 643- 644 ,(2014) , 10.1038/NRC3806
Holm Eggemann, Atanas Ignatov, Roland Stabenow, Gunter von Minckwitz, Friedrich Wilhelm Röhl, Peter Hass, Serban-Dan Costa, Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy Breast Care. ,vol. 8, pp. 270- 275 ,(2013) , 10.1159/000354122